These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5317468)

  • 1. Hazards of prolonged low-dose methotrexate therapy.
    Bender AS
    Va Med Mon (1918); 1970 Apr; 97(4):218-9. PubMed ID: 5317468
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of methotrexate in psoriasis.
    Roenigk HH; Maibach HI; Weinstein GD
    Arch Dermatol; 1972 Mar; 105(3):363-5. PubMed ID: 5012144
    [No Abstract]   [Full Text] [Related]  

  • 3. Methotrexate and the liver.
    Dahl MG
    Br J Dermatol; 1969 Jun; 81(6):465-7. PubMed ID: 4891127
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis.
    Weinstein GD; Cox JW; Suringa DW; Millard MM; Kalser M; Frost P
    Arch Dermatol; 1970 Dec; 102(6):613-8. PubMed ID: 5501902
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
    Tobias H; Auerbach R
    Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
    [No Abstract]   [Full Text] [Related]  

  • 6. Methotrexate in the treatment of psoriasis.
    Med Lett Drugs Ther; 1972 Jun; 14(12):41-2. PubMed ID: 4567562
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver injury associated with methotrexate therapy for psoriasis.
    Podurgiel BJ; McGill DB; Ludwig J; Taylor WF; Muller SA
    Mayo Clin Proc; 1973 Nov; 48(11):787-92. PubMed ID: 4758150
    [No Abstract]   [Full Text] [Related]  

  • 8. [Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy].
    Moldenhauer E; Dabels J; Diwok K; Leithäuser W; Nowotny P
    Dermatol Monatsschr; 1973 Mar; 159(3):242-8. PubMed ID: 4704945
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Roenigk HH; Bergfeld WF; St Jacques R; Owens FJ; Hawk WA
    Arch Dermatol; 1971 Mar; 103(3):250-61. PubMed ID: 5548272
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of methotrexate on the liver in psoriasis.
    Reese LT; Grisham JW; Aach RD; Eisen AZ
    J Invest Dermatol; 1974 Jun; 62(6):597-602. PubMed ID: 4835782
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver disease associated with methotrexate treatment of psoriatic patients.
    Dubin HV; Harrell ER
    Arch Dermatol; 1970 Nov; 102(5):498-503. PubMed ID: 5474111
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Palmer HM
    Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
    [No Abstract]   [Full Text] [Related]  

  • 13. Methotrexate therapy of psoriasis. Effect and side effects with particular reference to hepatic changes. A survey.
    Nyfors A
    Dan Med Bull; 1980 Apr; 27(2):74-96. PubMed ID: 7000451
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary and hepatic complications of methotrexate therapy of psoriasis.
    Filip DJ; Logue GL; Harle TS; Farrar WH
    JAMA; 1971 May; 216(5):881-2. PubMed ID: 5108291
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe liver damage caused by treatment of psoriasis with methotrexate.
    Pai SH; Werthamer S; Zak FG
    N Y State J Med; 1973 Nov; 73(21):2585-7. PubMed ID: 4518596
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate induced liver disease in psoriasis.
    Millward-Sadler GH; Ryan TJ
    Br J Dermatol; 1974 Jun; 90(6):661-7. PubMed ID: 4853200
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic chemotherapy for psoriasis: a national survey.
    Bergstresser PR; Schreiber SH; Weinstein GD
    Arch Dermatol; 1976 Jul; 112(7):977-81. PubMed ID: 947151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory and oligobiopsy examination of the liver in patients with psoriasis treated with methotrexate (preliminary report)].
    Ruszczak Z; Prószyńska-Kuczyńska W; Babiński S; Biernat S; Kulig A
    Przegl Dermatol; 1974; 61(6):803-7. PubMed ID: 4431967
    [No Abstract]   [Full Text] [Related]  

  • 19. [Damage due to treatment of psoriasis with folic acid antagonists].
    Randazzo SD; Chiarenza A; Lazzaro C
    G Ital Dermatol Minerva Dermatol; 1972 Feb; 47(2):77-81. PubMed ID: 4260377
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose methotrexate toxicity.
    Pivovarov K; Zipursky JS
    CMAJ; 2019 Apr; 191(15):E423. PubMed ID: 30988043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.